Nanotechnology used in medicine which manipulate the molecule such as on an atomic, molecular, and supramolecular scale and developed many new materials and devices with a vast range of applications, including nanomedicine, nanoelectronics, biomaterials energy production, and consumer products. Nanotechnology is most widely used to treat disease and prevent health issues. Nanotechnology in drug delivery development is the use of nanoparticles to deliver drugs to cancer cells. Nanotechnology Drug Delivery refers to the usage of nanoscale healthcare materials and technology in pharmaceutical drug delivery to improve the efficacy of the drug. Nanotechnology drug delivery is broadly used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. Most widely used in application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body. Nanotechnology drug delivery is a growing field in pharmaceutical industry and it contribute largest market share which rising adoption in health care applications. The nanotechnology drug delivery market is rapid growth due to increase in research and development activities in nanotechnology to develop novel nano-medicine.

Market scope and structure analysis:

COVID-19 Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Ongoing spread of COVID-19 impacted the growth of nanotechnology drug delivery market. Multidrug nanoparticles for the targeted delivery of drugs could be used to combat inflammation in COVID-19 patients, say researchers. Nano-based products are currently being developed for the control, diagnosis, and treatment of COVID-19. The nanotechnology used in COVID-19 have various feature such as Improved and virus disabling air filtration, Low-cost, scalable detection methods for the detection of viral particles, Enhanced personal protection equipment (PPE) including facemasks, New antiviral vaccine and drug delivery platforms, New therapeutic solutions, etc., which enhance the growth of nanotechnology drug delivery market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally, North America is the most dominance region in the nanotechnology drug delivery market due to the well-developed hospital facilities, presence of advanced technology and increasing incidence of chronic diseases such as cardiovascular diseases (CVD) and cancer. However, Europe is considered as a second largest share of the market due to the increasing number of pharmaceutical and biotechnology manufacturers owing to affordability for branded nanotechnology products by consumers. Whereas Asia-Pacific expected contribute market growth rate due to the increasing patient population and rising demand for nanotechnology drug product to treat the chronic diseases. 

In 2018, “National Cancer Institute”, state that around 1.73 million new cases of cancer will be diagnosed in the United States and more than 600,000 people died from the disease. In 2018, “World Health Organization” reported that due to the cardiovascular disease (CVD) around 24% of patient deaths was found in 2016 in Mexico. According to the “American Heart Association” reported that in 2016, around 840,678 deaths happened in US due to the Cardiovascular diseases which rising the demand for novel nanotechnology drug delivery technology.

The factor that drive the growth of nanotechnology drug delivery market such as growing awareness amongst the people regarding nanotechnology, increasing incidence of chronic diseases, rising government initiatives, and increasing demand for novel drug delivery,  increasing technological advancements, rising investment in nanotechnology. However, the factor such as high cost of medicines associated with nanotechnology and stringent government regulation are likely to restrain the growth of market 

New Product launch to flourish the market:

Major Key market manufacturer have been focusing on producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. In 2019, Taiwan Liposome Company has launched “LipAD“(Proprietary Lipid-Assembled Drug Delivery Platforms) TLC. This product creating solutions for long-lasting challenges in drug development by enabling new therapies with entirely unique properties. In 2018, “Nanobiotix”, has launched new drug product such as “Hensify®”. This is first-in-class product which introducing a new, physical mechanism of action and designed to physically destroy tumors and activate the immune system for both local control and systemic disease treatment when combined with radiation therapy. For instance, in 2011–2012, Pfizer, Inc., Amgen, Inc., and AstraZeneca signed agreements to collaborate with BIND Therapeutics to develop nano-medicines. These initiatives are expected to fuel the growth of the nanotechnology drug delivery market in the near future.

Key segments covered:

Key benefits of the report:

• This study presents the analytical depiction of the global nanotechnology drug delivery market along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global nanotechnology drug delivery market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the global nanotechnology drug delivery market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global nanotechnology drug delivery market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Nanotechnology Drug Delivery Market research report:

• Who are the leading market players active in nanotechnology drug delivery market?
• What are the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that will help in taking further strategic steps?

 Key Market Segments

 
Key Market Players

• Taiwan Liposome Company
• Nanobiotix
• NanoCarrier Corporation ltd
• Tarveda Therapeutics
• Aquanova AG
• AbbVie, Inc.
• Amgen, Inc.
• Celgene Corporation
• Johnson and Johnson
• Merck and Co., Inc.
• Novartis International AG,